Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal analysis of viral and host RNA in blood and saliva during controlled human dengue virus 3 infections.

Journal of virology·2026
Same author

Low-dose dengue virus 3 human challenge model: a phase 1 open-label study.

Nature microbiology·2024
Same author

Using Google Trends to Estimate the Geographic Distribution of Soil-Transmitted Helminthiasis in the United States from 2016 to 2021.

Tropical medicine and infectious disease·2023
Same author

Biologics for dengue prevention: up-to-date.

Expert opinion on biological therapy·2022
Same author

Evolution of inflammation and immunity in a dengue virus 1 human infection model.

Science translational medicine·2022
Same author

Simultaneous analysis of antigen-specific B and T cells after SARS-CoV-2 infection and vaccination.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2022

Related Experiment Video

Updated: Apr 28, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.4K

Dengue human infection model performance parameters.

Timothy P Endy1

  • 1Infectious Disease Division, Department of Medicine, State University of New York, Upstate Medical University, Syracuse.

The Journal of Infectious Diseases
|May 30, 2014
PubMed
Summary
This summary is machine-generated.

Developing an effective dengue vaccine is crucial for global health. A human dengue infection model is essential for testing new vaccines and antivirals against this mosquito-borne flavivirus.

Keywords:
denguehumaninfectionmodelvaccine

More Related Videos

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination
15:25

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination

Published on: July 4, 2007

21.4K
Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
08:36

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

33.7K

Related Experiment Videos

Last Updated: Apr 28, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.4K
Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination
15:25

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination

Published on: July 4, 2007

21.4K
Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
08:36

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

33.7K

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • Dengue viruses (DENVs) are mosquito-borne flaviviruses causing a significant global health burden.
  • Severe dengue illness involves intravascular volume depletion and hemorrhage, stemming from complex viral and host immune interactions.
  • Current dengue vaccine development faces challenges due to immunologic complexity and lack of adequate models.

Purpose of the Study:

  • To highlight the critical need for a dengue human infection model (DHIM).
  • To discuss the essential parameters for a DHIM to support vaccine and antiviral candidate development.

Main Methods:

  • Review of challenges in dengue vaccine development.
  • Discussion of requirements for a functional dengue human infection model.

Main Results:

  • A DHIM is identified as an essential tool for advancing dengue countermeasures.
  • Key performance parameters for a DHIM are outlined.

Conclusions:

  • A well-characterized DHIM is indispensable for the efficient development and licensure of effective dengue vaccines and antivirals.
  • Establishing a DHIM will accelerate the fight against dengue fever, a major public health concern.